Showing posts with label
Tildren
.
Show all posts
Showing posts with label
Tildren
.
Show all posts
Monday, March 25, 2019
Bisphosphonates Ban: Keeneland, Fasig-Tipton and Ocala Breeders’ Sales Ban Off-Label Use of Popular Navicular Disease Medication in Young Thoroughbreds
›
Bisphosphonates are a type of medication used to treat osteoporosis in humans. They have been approved by the US Food and Drug Adminis...
Monday, July 28, 2014
Navicular Syndrome: Does FDA Approval of Tildren and Osphos Change Anything?
›
From bone to zone: Focus on navicular-type lameness has evolved from concentrating on identifying bone defects visible in radiography to...
Tuesday, July 27, 2010
Tiludronate (Tildren) Effective for Hind Limb Lameness Caused by Bone Spavin
›
Spavin is one of the most common causes of lameness in jumping horses. Newly published trials from a study in England show that...
Saturday, April 21, 2007
Tildren: Denoix Study Shows Drug Helps Horses with Back Pain
›
Michael Davis, DVM, MS, of New England Equine Medical Center. Fran Jurga photo. Hoofcare and Lameness Journal first reported on the cl...
Monday, December 11, 2006
Study Targets Gene in Bone Loss Similar to Pedal Osteitis, Navicular Degeneration Equine Lameness Conditions
›
A CT scan of the equine distal limb reveals the bony architecture. Image courtesy of Alex zur Linden, DVM, DACVR, Assistant Professor of ...
›
Home
View web version
